2024-09-12

Eli Lilly to boost output of weight loss, diabetes, Alzheimer’s drugs

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and highly popular weight loss and diabetes treatments, among other medicines, in Ireland.  The pharmaceutical…

Read More

2024-09-09

Leqembi could give Alzheimer’s patients more time, but road to treatment is long

Hannah Yoon | The Washington Post | Getty Images Leqembi, an Alzheimer’s drug from Biogen and Eisai, isn’t a cure for the mind-damaging disease.  But the treatment promises to give patients such as Missie Meeks more time to live their daily lives normally and independently of others. Meeks, an English professor based in Ellisville, Mississippi, was diagnosed with an…

Read More

2024-09-06

AstraZeneca staff detained in China amid reported drug-import probe

The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024.  Nurphoto | Getty Images Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the company confirmed Thursday. “We are aware a small number of our employees in China are under investigation and…

Read More

2024-09-04

Weight loss drugs cut Covid-19 deaths, study finds

People taking the key component of blockbuster weight loss drugs Ozempic and Wegovy were less likely to die of Covid-19 or suffer adverse effects from the virus, researchers found in a new study. People who were already being treated with a 2.4 mg dose of the drug semaglutide — the active ingredient in pharma titan Novo Nordisk’s Ozempic and…

Read More

2024-08-28

Eli Lilly releases new, cheaper form of weight loss drug

Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage for the popular injection, such as those with Medicare.  The move also aims to expand the supply of Zepbound in the U.S. as demand skyrockets, and to ensure eligible…

Read More

2024-08-19

Why Walgreens, CVS retail pharmacies are struggling

The abundance of Walgreens and CVS Health stores makes them convenient for whenever Shriya Raghavan, a research associate based in Philadelphia, needs to pick up necessities like gum, deodorant and soap.  But she said she often has to wait for employees to unlock cabinets or stand in lengthy lines to pick up prescriptions as pharmacists juggle tasks. Those are…

Read More

2024-08-09

Eli Lilly (LLY) earnings Q2 2024

Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike. Shares of Eli Lilly closed more than 9% higher on Thursday. The drugmaker now expects revenue for the year to come in between…

Read More